83
Participants
Start Date
December 31, 2008
Primary Completion Date
March 31, 2011
Study Completion Date
March 31, 2011
Asacol 400 mg
"High dose:~17-\<33 kg = 3 Asacol 400mg in morning and 2 Asacol 400 in PM, 33-\<54 kg = 5 Asacol 400mg in morning and 4 Asacol 400 in PM, 54-\<90 kg = 6 Asacol 400mg in morning and 6 Asacol 400 in PM"
Asacol 400 mg
"Low dose:~17-\<33 kg = 2 Asacol 400mg + 1 placebo in morning and 1 Asacol 400 +1 placebo in PM, 33-\<54 kg = 3 Asacol 400mg +2 placebo in morning and 2 Asacol 400 + 2 placebo in PM, 54-\<90 kg = 3 Asacol 400mg + 3 placebo in morning and 3 Asacol 400mg + 3 placebo in PM"
Research Site, Zagreb
Research Facility, New Hyde Park
Research Facility, Buffalo
Research Facility, Washington D.C.
Research Facility, Norfolk
Research Facility, Huntington
Research Facility, Gainesville
Research Facility, Birmingham
Research Facility, Chattanooga
Research Facility, Knoxville
Research Facility, Louisville
Research Facility, Youngstown
Research Site, Rijeka
Research Facility, Park Ridge
Research Facility, Kansas City
Research Facility, Omaha
Research Facility, Fort Worth
Research Facility, Houston
Research Facility, San Antonio
Research Facility, Phoenix
Research Facility, San Diego
Research Facility, Loma Linda
Research Facility, San Francisco
Research Facility, San Francisco
Research Site, Iași
Research Facility, Boston
Research Facility, Worcester
Research Facility, Mays Landing
Research Facility, Portland
Research Facility, Halifax
Research Facility, Hamilton
Research Facility, London
Research Facility, Ottawa
Research Facility, Montreal
Research Site, Bialystok
Research Site, Bydgoszcz
Research Site, Krakow
Research Site, Lodz
Research Site, Warsazawa
Research Site, Wroclaw
Research Site, Bucharest
Research Site, Bucharest
Lead Sponsor
Warner Chilcott
INDUSTRY